Kestra Medical Technologies KMTS
NASDAQ KMTS
$27.31 -0.97 (-3.43%)
At close: Oct 21, 2026 · 4:00 PM EDT

Kestra Medical Technologies (KMTS) Current Deferred Revenue (2025)

Updated

Kestra Medical Technologies' Current Deferred Revenue came in at $460,000 for fiscal Q3 2025 (quarter ended Jan 31, 2025).

Analysis

Kestra Medical Technologies (KMTS) Current Deferred Revenue (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 257.99 Bn 237.02 Bn 4.88 Bn
2 Abbott Laboratories 175.01 Bn 145.44 Bn 7.27 Bn
3 Danaher 164.93 Bn 148.74 Bn 3.61 Bn
4 Intuitive Surgical 151.84 Bn 131.26 Bn 1.96 Bn
5 Medtronic 119.05 Bn 84.30 Bn 6.34 Bn
6 Stryker 113.89 Bn 100.00 Bn 4.50 Bn
7 Boston Scientific 65.37 Bn 60.13 Bn 3.85 Bn
8 Becton Dickinson 53.36 Bn 50.51 Bn 2.32 Bn
9 Edwards Lifesciences 50.83 Bn 34.83 Bn 1.35 Bn
10 Kestra Medical Technologies 1.62 Bn 1.37 Bn 17.50 Mn
Historic Data

Historic Data

Download Data
DateValue
Jan 31, 2025 460,000.00
API Access

Kestra Medical Technologies Current Deferred Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=KMTS&period=max&api_key=YOUR_API_KEY